StockNews.com began coverage on shares of H.B. Fuller (NYSE:FUL – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a hold rating on the specialty chemicals company’s stock.
A number of other analysts have also weighed in on FUL. Robert W. Baird cut their price objective on H.B. Fuller from $85.00 to $80.00 and set an outperform rating on the stock in a research report on Friday, January 20th. Deutsche Bank Aktiengesellschaft upped their price objective on H.B. Fuller from $72.00 to $78.00 in a research report on Friday, January 20th. Finally, Citigroup upgraded shares of H.B. Fuller from a neutral rating to a buy rating and boosted their target price for the stock from $72.00 to $85.00 in a research note on Friday, February 3rd. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, H.B. Fuller currently has an average rating of Hold and a consensus target price of $73.75.
H.B. Fuller Stock Down 1.3 %
Shares of NYSE FUL opened at $64.65 on Thursday. H.B. Fuller has a 52-week low of $57.36 and a 52-week high of $81.41. The business’s 50 day moving average is $70.29 and its two-hundred day moving average is $70.04. The company has a quick ratio of 1.14, a current ratio of 1.84 and a debt-to-equity ratio of 1.08. The firm has a market cap of $3.48 billion, a price-to-earnings ratio of 19.83 and a beta of 1.54.
H.B. Fuller Announces Dividend
Insider Buying and Selling at H.B. Fuller
In other H.B. Fuller news, VP Timothy J. Keenan sold 2,836 shares of the company’s stock in a transaction on Thursday, February 9th. The shares were sold at an average price of $71.80, for a total value of $203,624.80. Following the completion of the transaction, the vice president now owns 19,803 shares in the company, valued at $1,421,855.40. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 4.50% of the stock is currently owned by insiders.
Institutional Investors Weigh In On H.B. Fuller
Several hedge funds have recently made changes to their positions in FUL. MetLife Investment Management LLC boosted its stake in shares of H.B. Fuller by 55.7% during the first quarter. MetLife Investment Management LLC now owns 27,833 shares of the specialty chemicals company’s stock worth $1,839,000 after buying an additional 9,960 shares during the period. Luminus Management LLC acquired a new stake in shares of H.B. Fuller during the first quarter worth about $3,396,000. Mutual of America Capital Management LLC boosted its stake in shares of H.B. Fuller by 17.0% during the second quarter. Mutual of America Capital Management LLC now owns 8,910 shares of the specialty chemicals company’s stock worth $536,000 after buying an additional 1,297 shares during the period. Dorsey & Whitney Trust CO LLC boosted its stake in shares of H.B. Fuller by 1.8% during the second quarter. Dorsey & Whitney Trust CO LLC now owns 60,092 shares of the specialty chemicals company’s stock worth $3,618,000 after buying an additional 1,090 shares during the period. Finally, UBS Asset Management Americas Inc. boosted its stake in shares of H.B. Fuller by 4.9% during the second quarter. UBS Asset Management Americas Inc. now owns 66,538 shares of the specialty chemicals company’s stock worth $4,006,000 after buying an additional 3,081 shares during the period. Institutional investors and hedge funds own 96.53% of the company’s stock.
H.B. Fuller Company Profile
H.B. Fuller Co engages in the manufacture and marketing of adhesives, sealants, and other chemical products. It operates through the following business segments: Hygiene, Health, and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. The Hygiene, Health, and Consumable Adhesives segment supplies adhesive products in the assembly, packaging, converting, nonwoven, hygiene, health and beauty, flexible packaging, graphic arts, and envelope markets.
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.